Cargando…
Neuroleptic Malignant Syndrome in a Patient with Corticobasal Degeneration
Parkinson’s disease is a principal underlying disease of neuroleptic malignant syndrome (NMS) occurring in parkinsonian disorders, but NMS may occur in patients with progressive supranuclear palsy and multiple system atrophy. We report first patient with corticobasal degeneration (CBD) who developed...
Autores principales: | Lee, Myung Jun, Lyoo, Chul Hyoung, Lee, Myung Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027684/ https://www.ncbi.nlm.nih.gov/pubmed/24868399 http://dx.doi.org/10.14802/jmd.11015 |
Ejemplares similares
-
Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014) -
Corticobasal degeneration and corticobasal syndrome: A review
por: Constantinides, Vasilios C., et al.
Publicado: (2019) -
Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016) -
Clozapine Induced Neuroleptic Malignant Syndrome
por: Jo, Yong Suk, et al.
Publicado: (2017) -
A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously
por: Lee, Jae Hyeok, et al.
Publicado: (2011)